Brady Todd C
SEC insider (Form 3/4/5 filer). CIK 0001579179. President and CEO at Aldeyra Therapeutics, Inc. (ALDX) and 1 other issuer. 8 reported Form 4/5 transactions since Sep 2024; latest on Jun 3, 2026. Located in LEXINGTON, MA.
Companies Brady Todd C has filed insider reports for
- Aldeyra Therapeutics, Inc. (ALDX): Director, Officer, President and CEO
- Evoke Pharma Inc (EVOK): Director
Brady Todd C
CIK: 0001579179
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jun 3, 2026ALDX
Aldeyra Therapeutics, Inc.
PurchaseDirect250K shares at avg. $1.67$418K - Dec 17, 2025EVOK
Evoke Pharma Inc
DispositionDirectStock Option (Right to Buy)
1.2K shares- - Dec 17, 2025EVOK
Evoke Pharma Inc
DispositionDirectStock Option (Right to Buy)
1.2K shares- - Dec 17, 2025EVOK
Evoke Pharma Inc
DispositionDirectStock Option (Right to Buy)
5.8K shares- - Dec 16, 2025EVOK
Evoke Pharma Inc
Tender OfferDirect27 shares- - May 21, 2025EVOK
Evoke Pharma Inc
AwardDirectStock Option (Right to Buy)
1.2K shares- - Mar 4, 2025ALDX
Aldeyra Therapeutics, Inc.
AwardDirectStock Option (right to buy)
809.7K shares- - Jan 28, 2025EVOK
Evoke Pharma Inc
AwardDirectStock Option (Right to Buy)
5.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 3, 2026 |  ALDX Aldeyra Therapeutics, Inc. | Purchase | 250,000 | $1.67 | $418,450 | Direct |
| Dec 17, 2025 |  EVOK Evoke Pharma Inc | Disposition Stock Option (Right to Buy) | 1,187 | - | - | Direct |
| Dec 17, 2025 | EVOK Evoke Pharma Inc | Disposition Stock Option (Right to Buy) | 1,218 | - | - | Direct |
| Dec 17, 2025 | EVOK Evoke Pharma Inc | Disposition Stock Option (Right to Buy) | 5,833 | - | - | Direct |
| Dec 16, 2025 | EVOK Evoke Pharma Inc | Tender Offer | 27 | - | - | Direct |
| May 21, 2025 | EVOK Evoke Pharma Inc | Award Stock Option (Right to Buy) | 1,187 | - | - | Direct |
| Mar 4, 2025 | ALDX Aldeyra Therapeutics, Inc. | Award Stock Option (right to buy) | 809,710 | - | - | Direct |
| Jan 28, 2025 | EVOK Evoke Pharma Inc | Award Stock Option (Right to Buy) | 5,833 | - | - | Direct |
1-8 of 8 transactions